ASHLEY PRICE: Open Payments
NPI 1508593690 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 48 payments from 15 companies in 2025. Trend: 2023 $1,104 · 2024 $905 · 2025 $891
Food & beverage: $791Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $235 |
| E.R. Squibb & Sons, L.L.C. | 7 | $180 |
| UCB, Inc. | 4 | $88 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| GENZYME CORPORATION | 2 | $48 |
| Incyte Corporation | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: COSENTYX, Sotyktu, Bimzelx, DUPIXENT, Zoryve, OPZELURA, NEMLUVIO, SKYRIZI.
Industry payments across MS — which companies pay providers there.
